MAM
Monaco Asset Management Portfolio holdings
AUM
$264M
This Quarter Return
-14.35%
1 Year Return
+6.34%
3 Year Return
+31.77%
5 Year Return
–
10 Year Return
–
AUM
$217M
AUM Growth
+$217M
(+15%)
Cap. Flow
+$48.2M
Cap. Flow
% of AUM
22.18%
Top 10 Holdings %
Top 10 Hldgs %
58.25%
Holding
75
New
29
Increased
19
Reduced
11
Closed
4
Top Buys
| 1 |
Netflix
NFLX
|
$10.5M |
| 2 |
Bunge Global
BG
|
$4.44M |
| 3 |
Noble Corp
NE
|
$4.12M |
| 4 |
PayPal
PYPL
|
$4.02M |
| 5 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$3.63M |
Top Sells
| 1 |
Viatris
VTRS
|
$5.02M |
| 2 |
TechnipFMC
FTI
|
$4.28M |
| 3 |
AT&T
T
|
$1.77M |
| 4 |
Esperion Therapeutics
ESPR
|
$1.57M |
| 5 |
XYZ
Block, Inc.
XYZ
|
$1.36M |
Sector Composition
| 1 | Energy | 28.35% |
| 2 | Healthcare | 15.91% |
| 3 | Materials | 9.24% |
| 4 | Communication Services | 9.22% |
| 5 | Consumer Discretionary | 5.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Kohl's
KSS
$1.72B
| $2.14M | 0.93% |
+60,000
| New | +$2.14M |
|
27
Alico
ALCO
$261M
| $2.12M | 0.92% |
+59,623
| New | +$2.12M |
|
28
Alamos Gold
AGI
$13.3B
| $1.76M | 0.76% |
250,000
+25,000
| +11% | +$176K |
|
29
Oric Pharmaceuticals
ORIC
$999M
| $1.63M | 0.71% |
+364,741
| New | +$1.63M |
|
30
Sprott Physical Silver Trust
PSLV
$7.61B
| $1.59M | 0.69% |
230,000
| – | – |
|
|
NBIS
31
Nebius Group N.V. Class A Ordinary Shares
NBIS
$15.4B
| $1.57M | 0.68% |
105,000
| – | – |
|
|
DO
32
DELISTED
Diamond Offshore Drilling, Inc.
DO
| $1.33M | 0.58% |
+225,000
| New | +$1.33M |
|
|
BLUE
33
DELISTED
bluebird bio
BLUE
| $1.27M | 0.55% |
+306,142
| New | +$1.27M |
|
34
Vistra
VST
$62.3B
| $1.26M | 0.55% |
+55,000
| New | +$1.26M |
|
35
StoneCo
STNE
$4.35B
| $1.12M | 0.49% |
145,000
+45,000
| +45% | +$347K |
|
36
Cue Biopharma
CUE
$60.9M
| $1.11M | 0.48% |
443,851
+398,851
| +886% | +$993K |
|
|
37
Esperion Therapeutics
ESPR
$458M
| $1.1M | 0.48% |
172,500
-246,762
| -59% | -$1.57M |
|
38
Sibanye-Stillwater
SBSW
$5.88B
| $1.05M | 0.46% |
+105,000
| New | +$1.05M |
|
39
DNOW Inc
DNOW
$1.67B
| $978K | 0.43% |
100,000
-115,494
| -54% | -$1.13M |
|
40
Gold Fields
GFI
$31B
| $958K | 0.42% |
+105,000
| New | +$958K |
|
41
AdvisorShares Pure US Cannabis ETF
MSOS
$908M
| $880K | 0.38% |
85,000
-10,000
| -11% | -$104K |
|
42
New Oriental
EDU
$8.03B
| $814K | 0.35% |
40,000
-45,000
| -53% | -$916K |
|
43
Bausch Health
BHC
$2.85B
| $773K | 0.34% |
+92,474
| New | +$773K |
|
44
ProQR Therapeutics
PRQR
$235M
| $724K | 0.32% |
931,400
+840,500
| +925% | +$653K |
|
|
CELL
45
DELISTED
PhenomeX Inc. Common Stock
CELL
| $721K | 0.31% |
145,000
+50,000
| +53% | +$249K |
|
46
Smith & Wesson
SWBI
$359M
| $650K | 0.28% |
49,500
+34,000
| +219% | +$446K |
|
47
Vipshop
VIPS
$8.28B
| $643K | 0.28% |
65,000
-98,497
| -60% | -$974K |
|
48
Chemours
CC
$2.26B
| $640K | 0.28% |
+20,000
| New | +$640K |
|
|
ZEN
49
DELISTED
ZENDESK INC
ZEN
| $556K | 0.24% |
+7,500
| New | +$556K |
|
50
Adverum Biotechnologies
ADVM
$63.2M
| $536K | 0.23% |
+447,004
| New | +$536K |
|